Acquired thrombotic thrombocytopenic purpura after AstraZeneca vaccine: A case report

BACKGROUND: Rare cases of acquired thrombotic thrombocytopenic purpura (aTTP) have been reported since the administration of the COVID-19 vaccination. Based on our information, the present study provides the first case report of aTTP developed after the COVID-19 vaccination in Iran. CASE PRESENTATIO...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaghoubi, Fatemeh, Dalil, Davood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Babol University of Medical Sciences 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272963/
https://www.ncbi.nlm.nih.gov/pubmed/35872667
http://dx.doi.org/10.22088/cjim.13.0.299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272963/
https://www.ncbi.nlm.nih.gov/pubmed/35872667
http://dx.doi.org/10.22088/cjim.13.0.299

Ejemplares similares